Latest Period
Q1 2026
Security Snapshot
HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) Institutional Ownership
CUSIP: 405024100
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
324
Shares (Excl. Options)
47,621,777
Price
$56.36
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, $.01 par value per share
- Symbol
- HAE on NYSE
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 47,621,777
- Total 13F value
- $2,681,997,561
- Portfolio coverage rank
- 0%
- Share change
- -3,435,917
- Value change
- -$232,006,407
- Number of holders
- 324
- Shares outstanding
- 46,498,422
- SEC-reported price per share
- $67.04
- Insider filing price
- $67.04
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- HAE - HAEMONETICS CORP - Common stock, $.01 par value per share is tracked under CUSIP 405024100.
- 324 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 329 to 324 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $4,075,910,711 to $2,681,997,561.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 324 institutions filings for Q1 2026.
Security key
405024100
Latest holder period
Q1 2026
13F holders
324
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
HAE full holder history
HAEMONETICS CORP SEC filings
HAEMONETICS CORP company facts
HAEMONETICS CORP insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 405024100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
HAE
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| AQR CAPITAL MANAGEMENT LLC | 6.8% | $253,522,786 | 3,163,104 | AQR Capital Management, LLC | 31 Dec 2025 | |||
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.6% | $146,544,172 | 2,600,145 | Vanguard Portfolio Management | 31 Mar 2026 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5.3% | $137,846,246 | 2,445,817 | Vanguard Capital Management | 31 Mar 2026 | |||
| WELLINGTON MANAGEMENT GROUP LLP | 4.6% | -16% | $165,537,761 | -$36,448,193 | 2,203,351 | -18% | Wellington Management Group LLP | 30 Jun 2025 |
| T. Rowe Price Investment Management, Inc. | 4.4% | $135,949,632 | 2,195,569 | T. Rowe Price Investment Management, Inc. | 31 Mar 2025 | |||
| Capital Research Global Investors | 3.1% | $97,667,840 | 1,577,323 | Capital Research Global Investors | 31 Mar 2025 |
As of 31 Mar 2026, 324 institutional investors reported holding 47,621,777 shares of HAEMONETICS CORP - Common stock, $.01 par value per share (HAE). This represents 102% of the company’s total 46,498,422 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
75%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | 5,619,979 | -3.5% | 0.01% | $316,742,027 |
| NEUBERGER BERMAN GROUP LLC | 7.7% | 3,560,918 | -7.9% | 0.15% | $200,613,400 |
| AQR CAPITAL MANAGEMENT LLC | 7.2% | 3,356,543 | +6.1% | 0.09% | $185,683,959 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.5% | 2,559,316 | 0% | 0.01% | $144,243,050 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 2,090,389 | 0% | 0% | $117,814,324 |
| STATE STREET CORP | 3.8% | 1,772,898 | +2.5% | 0% | $99,920,531 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3% | 1,383,004 | +0.21% | 0.04% | $77,946,105 |
| River Road Asset Management, LLC | 2.9% | 1,327,989 | +20% | 0.85% | $74,845,460 |
| DIMENSIONAL FUND ADVISORS LP | 2.9% | 1,326,057 | +21% | 0.02% | $74,730,645 |
| FMR LLC | 2.7% | 1,275,886 | -3.8% | 0% | $71,908,935 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 1,218,978 | +2% | 0% | $68,713,808 |
| North Peak Capital Management, LLC | 2.1% | 998,953 | -9.4% | 9.4% | $56,300,991 |
| GOLDMAN SACHS GROUP INC | 2% | 952,820 | -22% | 0.01% | $53,700,964 |
| Allspring Global Investments Holdings, LLC | 1.9% | 890,224 | -5.3% | 0.08% | $50,066,198 |
| ROYAL BANK OF CANADA | 1.8% | 857,965 | -11% | 0.01% | $48,354,000 |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 1.8% | 841,017 | +17% | 0.26% | $47,399,718 |
| Invenomic Capital Management LP | 1.4% | 664,729 | 1.7% | $37,464,126 | |
| T. Rowe Price Investment Management, Inc. | 1.3% | 597,155 | -37% | 0.02% | $33,656,000 |
| NORTHERN TRUST CORP | 1.2% | 579,306 | +0.27% | 0% | $32,649,687 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.2% | 572,100 | +4.2% | 0% | $32,243,556 |
| Boston Partners | 1.2% | 556,679 | +73% | 0.03% | $31,418,477 |
| UBS Group AG | 1.1% | 526,617 | -2.4% | 0.01% | $29,680,134 |
| BANK OF AMERICA CORP /DE/ | 1.1% | 512,183 | +6.2% | 0% | $28,866,634 |
| Boston Trust Walden Corp | 1.1% | 501,885 | -14% | 0.23% | $28,286,239 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 1.1% | 491,747 | -14% | 0.2% | $27,715,026 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 47,621,777 | $2,681,997,561 | -$232,006,407 | $56.36 | 324 |
| 2025 Q4 | 50,859,989 | $4,075,910,711 | +$58,180,392 | $80.15 | 329 |
| 2025 Q3 | 51,319,539 | $2,500,166,518 | -$232,706,500 | $48.74 | 298 |
| 2025 Q2 | 54,253,774 | $4,048,407,950 | +$51,089,014 | $74.61 | 297 |
| 2025 Q1 | 53,724,229 | $3,412,895,600 | -$212,763,194 | $63.55 | 313 |
| 2024 Q4 | 56,558,011 | $4,415,683,452 | +$40,389,204 | $78.08 | 305 |
| 2024 Q3 | 55,858,330 | $4,486,624,929 | -$21,003,128 | $80.38 | 303 |
| 2024 Q2 | 55,851,715 | $4,621,294,419 | +$385,980,667 | $82.73 | 315 |
| 2024 Q1 | 51,176,074 | $4,367,618,453 | +$50,781,270 | $85.35 | 296 |
| 2023 Q4 | 50,568,886 | $4,325,205,912 | -$20,996,057 | $85.51 | 294 |
| 2023 Q3 | 50,792,206 | $4,551,407,114 | +$20,351,169 | $89.58 | 294 |
| 2023 Q2 | 50,542,703 | $4,303,570,562 | +$14,249,115 | $85.14 | 288 |
| 2023 Q1 | 50,384,868 | $4,169,004,070 | +$9,612,280 | $82.75 | 294 |
| 2022 Q4 | 50,382,562 | $3,963,254,277 | -$107,357,997 | $78.65 | 287 |
| 2022 Q3 | 51,775,808 | $3,833,648,345 | -$28,085,090 | $74.03 | 260 |
| 2022 Q2 | 52,080,593 | $3,394,785,256 | +$49,689,135 | $65.18 | 229 |
| 2022 Q1 | 51,567,377 | $3,257,869,910 | +$120,748,445 | $63.22 | 225 |
| 2021 Q4 | 50,084,803 | $2,655,680,021 | -$87,203,336 | $53.04 | 240 |
| 2021 Q3 | 50,697,310 | $3,576,779,438 | +$7,330,940 | $70.59 | 239 |
| 2021 Q2 | 50,672,122 | $3,375,443,272 | -$52,557,812 | $66.64 | 249 |
| 2021 Q1 | 49,961,531 | $5,549,106,460 | -$22,300,347 | $111.01 | 288 |
| 2020 Q4 | 49,701,181 | $5,902,338,582 | +$13,637,273 | $118.75 | 278 |
| 2020 Q3 | 49,419,749 | $4,312,359,704 | -$6,823,951 | $87.25 | 261 |
| 2020 Q2 | 49,513,911 | $4,436,797,359 | -$134,065,133 | $89.56 | 276 |
| 2020 Q1 | 50,595,124 | $5,040,192,796 | +$54,162,521 | $99.66 | 263 |